Meta-analyses, however, have not demonstrated any meaningful increase in aspiration risk when therapy is continued [10]
One study found that 32% of patients receiving IV glutathione experienced adverse events, including liver dysfunction and one case of anaphylaxis.[8] The FDA has issued warnings about contaminated IV glutathione causing hospitalizations.[9] Theres no long-term safety data for ongoing IV use
GLP-1, a product of the glucagon gene, is produced in L-cells of the small intestine
Clinicians should be aware that creatinine-based eGFR may underestimate true kidney function in creatine users
Experts do not generally consider ibuprofen to be a medication that will lead to substance use disorder, although at least one The body does not build up a tolerance to it, so a person will not need larger doses for the same effect
10.1039/C6MB00600K 58 GermainA.RuppertD.LevineS